Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 01, 2026 Filed Jul 2, 2026 15:09 UTC |
Bohra Dipak KumarGroup Chief Financial Officer
|
GrantRestricted Stock Units · Derivative | 3,906 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-293805 · ownership.xml · derivative · entry 1 Bohra Dipak Kumar · CIK 0002110566 · Group Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,906 Underlying: Ordinary Shares · 3,906 shares Expires not disclosed F1 · derivative.exercise_date: The Restricted Stock Units are scheduled to vest between April 1, 2027 to April 1, 2030, with expiration dates ranging from March 31, 2031 to March 31, 2034, subject to extension at the sole discretion of the Company and include 1,953 performance-based Restricted Stock Units relating to 1,953 Ordinary Shares subject to achievement of certain performance-based vesting conditions. F1 · derivative.expiration_date: The Restricted Stock Units are scheduled to vest between April 1, 2027 to April 1, 2030, with expiration dates ranging from March 31, 2031 to March 31, 2034, subject to extension at the sole discretion of the Company and include 1,953 performance-based Restricted Stock Units relating to 1,953 Ordinary Shares subject to achievement of certain performance-based vesting conditions. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 15:03 UTC |
Kabra MohitDirector · Group Chief Operating Officer
|
GrantRestricted Stock Units · Derivative | 788 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-293785 · ownership.xml · derivative · entry 2 Kabra Mohit · CIK 0001971628 · Director · Group Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,541 Underlying: Ordinary Shares · 788 shares Expires not disclosed F2 · derivative.exercise_date: Performance-based Restricted Stock Units are scheduled to vest on September 30, 2026 with the expiration date May 31, 2030, subject to extension at the sole discretion of the Company. F2 · derivative.expiration_date: Performance-based Restricted Stock Units are scheduled to vest on September 30, 2026 with the expiration date May 31, 2030, subject to extension at the sole discretion of the Company. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 15:03 UTC |
Kabra MohitDirector · Group Chief Operating Officer
|
GrantRestricted Stock Units · Derivative | 26,358 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-293785 · ownership.xml · derivative · entry 1 Kabra Mohit · CIK 0001971628 · Director · Group Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,358 Underlying: Ordinary Shares · 26,358 shares Expires not disclosed F1 · derivative.exercise_date: The Restricted Stock Units are scheduled to vest between April 1, 2027 to April 1, 2030, with expiration dates ranging from March 31, 2031 to March 31, 2034, subject to extension at the sole discretion of the Company and include 13,179 performance-based Restricted Stock Units relating to 13,179 Ordinary Shares subject to achievement of certain performance-based vesting conditions. F1 · derivative.expiration_date: The Restricted Stock Units are scheduled to vest between April 1, 2027 to April 1, 2030, with expiration dates ranging from March 31, 2031 to March 31, 2034, subject to extension at the sole discretion of the Company and include 13,179 performance-based Restricted Stock Units relating to 13,179 Ordinary Shares subject to achievement of certain performance-based vesting conditions. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 15:00 UTC |
Magow RajeshDirector · Group Chief Executive Officer
|
GrantRestricted Stock Units · Derivative | 27,098 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-293777 · ownership.xml · derivative · entry 2 Magow Rajesh · CIK 0001971627 · Director · Group Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 252,914 Underlying: Ordinary Shares · 27,098 shares Expires not disclosed F2 · derivative.exercise_date: Performance-based Restricted Stock Units are scheduled to vest on September 30, 2026 with the expiration date March 31, 2031, subject to extension at the sole discretion of the Company. F2 · derivative.expiration_date: Performance-based Restricted Stock Units are scheduled to vest on September 30, 2026 with the expiration date March 31, 2031, subject to extension at the sole discretion of the Company. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 15:00 UTC |
Magow RajeshDirector · Group Chief Executive Officer
|
GrantRestricted Stock Units · Derivative | 29,478 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-293777 · ownership.xml · derivative · entry 1 Magow Rajesh · CIK 0001971627 · Director · Group Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,478 Underlying: Ordinary Shares · 29,478 shares Expires not disclosed F1 · derivative.exercise_date: The Restricted Stock Units are scheduled to vest between April 1, 2027 to April 1, 2030, with expiration dates ranging from March 31, 2031 to March 31, 2034, subject to extension at the sole discretion of the Company, and include 14,739 performance-based Restricted Stock Units relating to 14,739 Ordinary Shares subject to the achievement of certain performance-based vesting conditions. F1 · derivative.expiration_date: The Restricted Stock Units are scheduled to vest between April 1, 2027 to April 1, 2030, with expiration dates ranging from March 31, 2031 to March 31, 2034, subject to extension at the sole discretion of the Company, and include 14,739 performance-based Restricted Stock Units relating to 14,739 Ordinary Shares subject to the achievement of certain performance-based vesting conditions. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 14:51 UTC |
Deep KalraDirector
|
GrantRestricted Stock Units · Derivative | 470 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-293752 · ownership.xml · derivative · entry 2 Deep Kalra · CIK 0001971624 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,870 Underlying: Ordinary Shares · 470 shares Expires not disclosed F2 · derivative.exercise_date: Performance-based Restricted Stock Units are scheduled to vest on September 30, 2026 with the expiration date May 31, 2030, subject to extension at the sole discretion of the Company. F2 · derivative.expiration_date: Performance-based Restricted Stock Units are scheduled to vest on September 30, 2026 with the expiration date May 31, 2030, subject to extension at the sole discretion of the Company. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 14:51 UTC |
Deep KalraDirector
|
GrantRestricted Stock Units · Derivative | 12,406 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-293752 · ownership.xml · derivative · entry 1 Deep Kalra · CIK 0001971624 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,406 Underlying: Ordinary Shares · 12,406 shares Expires not disclosed F1 · derivative.exercise_date: The Restricted Stock Units are scheduled to vest between April 1, 2027 to April 1, 2030, with expiration dates ranging from March 31, 2031 to March 31, 2034, subject to extension at the sole discretion of the Company and include 6,203 performance-based Restricted Stock Units relating to 6,203 Ordinary Shares subject to achievement of certain performance-based vesting conditions. F1 · derivative.expiration_date: The Restricted Stock Units are scheduled to vest between April 1, 2027 to April 1, 2030, with expiration dates ranging from March 31, 2031 to March 31, 2034, subject to extension at the sole discretion of the Company and include 6,203 performance-based Restricted Stock Units relating to 6,203 Ordinary Shares subject to achievement of certain performance-based vesting conditions. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.